Claire Vale

Summary

Affiliation: National Institute for Medical Research
Country: UK

Publications

  1. doi request reprint Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviews
    Claire L Vale
    Meta analysis Group, MRC Clinical Trials Unit, London WC2B 6NH, UK
    BMJ 346:f1798. 2013
  2. doi request reprint Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
    Claire L Vale
    Meta analysis Group, MRC Clinical Trials Unit, London, UK Hidden
    Cochrane Database Syst Rev 8:CD003915. 2012
  3. doi request reprint Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis
    Claire L Vale
    Medical Research Council Clinical Trials Unit, Aviation House, 125 Kingsway, London WC2B 6NH, UK
    Cancer Treat Rev 38:618-25. 2012
  4. pmc Involvement of consumers in studies run by the Medical Research Council Clinical Trials Unit: results of a survey
    Claire L Vale
    MRC Clinical Trials Unit, London, UK
    Trials 13:9. 2012
  5. ncbi request reprint Effects of adjusting for censoring on meta-analyses of time-to-event outcomes
    Claire L Vale
    Meta analysis Group, MRC Clinical Trials Unit, London, UK
    Int J Epidemiol 31:107-11. 2002

Detail Information

Publications6

  1. doi request reprint Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviews
    Claire L Vale
    Meta analysis Group, MRC Clinical Trials Unit, London WC2B 6NH, UK
    BMJ 346:f1798. 2013
    ..To evaluate the reliability of risk of bias assessments based on published trial reports, for determining trial inclusion in meta-analyses...
  2. doi request reprint Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
    Claire L Vale
    Meta analysis Group, MRC Clinical Trials Unit, London, UK Hidden
    Cochrane Database Syst Rev 8:CD003915. 2012
    ..Co-morbidity, including obesity and cardiac disease, and concerns over toxicity have prevented more extensive studies of cytotoxic chemotherapy, although there are a number of active agents...
  3. doi request reprint Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis
    Claire L Vale
    Medical Research Council Clinical Trials Unit, Aviation House, 125 Kingsway, London WC2B 6NH, UK
    Cancer Treat Rev 38:618-25. 2012
    ..Randomised controlled trials (RCTs) of anti-EGFR monoclonal antibodies (MAb) in patients with advanced colorectal cancer (aCRC) have reported conflicting results...
  4. pmc Involvement of consumers in studies run by the Medical Research Council Clinical Trials Unit: results of a survey
    Claire L Vale
    MRC Clinical Trials Unit, London, UK
    Trials 13:9. 2012
    ....
  5. ncbi request reprint Effects of adjusting for censoring on meta-analyses of time-to-event outcomes
    Claire L Vale
    Meta analysis Group, MRC Clinical Trials Unit, London, UK
    Int J Epidemiol 31:107-11. 2002
    ..We have assessed the impact of adjusting for censoring on weighting, estimates and statistical heterogeneity of meta-analyses in cancer...